Hemopressin as a breakthrough for the cannabinoid field (2021)
Fonte: Neuropharmacology. Unidades: ICB, FMRP
Assuntos: ANATOMIA, FARMACOLOGIA, CANABINOIDES, RECEPTORES, PEPTÍDEOS, HEMOGLOBINAS, CAMUNDONGOS, MITOCÔNDRIAS, ANTI-INFLAMATÓRIOS, MATERIAIS NANOESTRUTURADOS
ABNT
HEIMANN, Andrea S. et al. Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, v. 183, p. 12 , 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2020.108406. Acesso em: 18 nov. 2024.APA
Heimann, A. S., Dale, C. S., Guimarães, F. S., Reis, R. A. M., Navon, A., Shmuelov, M. A., et al. (2021). Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, 183, 12 . doi:10.1016/j.neuropharm.2020.108406NLM
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406Vancouver
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406